Work

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.630.630

Authors: David P Steensma, Shaker R. Dakhil, Robert Dalton, Stephen P Kahanic, John W Kugler, Philip J Stella, Kendrith M Rowland, Paul J Novotny, Jeff A Sloan, Charles L Loprinzi

Institutions: Dana-Farber Cancer Institute, Cancer Center of Kansas, Mayo Clinic, Illinois CancerCare

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980274553

FWCI: 0.877

Cites:

Cited by: 11

Related to: 10